GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 60 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 60 Fair valued | |
PROFIT vs RISK RATING 1..100 | 44 | |
SMR RATING 1..100 | 35 | |
PRICE GROWTH RATING 1..100 | 54 | |
P/E GROWTH RATING 1..100 | 59 | |
SEASONALITY SCORE 1..100 | 55 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| EWU | GSK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 71% | N/A |
| Stochastic ODDS (%) | 2 days ago 73% | 2 days ago 57% |
| Momentum ODDS (%) | 2 days ago 86% | 2 days ago 44% |
| MACD ODDS (%) | N/A | 2 days ago 42% |
| TrendWeek ODDS (%) | 2 days ago 82% | 2 days ago 53% |
| TrendMonth ODDS (%) | 2 days ago 78% | 2 days ago 49% |
| Advances ODDS (%) | 9 days ago 81% | 7 days ago 62% |
| Declines ODDS (%) | 3 days ago 75% | 2 days ago 54% |
| BollingerBands ODDS (%) | 2 days ago 79% | 2 days ago 45% |
| Aroon ODDS (%) | 2 days ago 78% | 2 days ago 64% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RGLO | 33.91 | 0.19 | +0.58% |
| Russell Inv Global Equity ETF | |||
| MRCP | 35.08 | 0.10 | +0.29% |
| PGIM S&P 500 Buffer 12 ETF - Mar | |||
| HYS | 92.87 | 0.13 | +0.14% |
| PIMCO 0-5 Year High Yield Corp Bd ETF | |||
| LDRT | 24.96 | 0.02 | +0.10% |
| iShares iBonds 1-5 Year Treasury Ladder ETF | |||
| MFSM | 24.86 | 0.02 | +0.10% |
| MFS Active Intermediate Muni Bond ETF | |||
A.I.dvisor indicates that over the last year, EWU has been closely correlated with NWG. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if EWU jumps, then NWG could also see price increases.
A.I.dvisor indicates that over the last year, GSK has been loosely correlated with NVS. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if GSK jumps, then NVS could also see price increases.